Navigating financial toxicity in patients with cancer: A multidisciplinary management approach
Grace L. Smith(The University of Texas MD Anderson Cancer Center), K. Robin Yabroff(American Cancer Society), Veena Shankaran(University of Washington), Maria Pisu(University of Alabama at Birmingham), Rena M. Conti(University of Chicago), Michael Roth(The University of Texas MD Anderson Cancer Center), Margaret Liang(Cedars-Sinai Medical Center), Chiara Acquati(The University of Texas MD Anderson Cancer Center), Shine Chang(The University of Texas MD Anderson Cancer Center), Juliet L. Kroll(The University of Texas MD Anderson Cancer Center), Kristin Primm(The University of Texas MD Anderson Cancer Center), Rachel A. Greenup(Yale University), Matthew P. Banegas(University of California San Diego), Fumiko Chino(The University of Texas MD Anderson Cancer Center)
Cited by 251
Related Papers
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Financial Hardships Experienced by Cancer Survivors: A Systematic Review
|JNCI Journal of the National Cancer Institute|2016|825
Pricing in the Market for Anticancer Drugs
|The Journal of Economic Perspectives|2015|444
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
|JNCI Journal of the National Cancer Institute|2006|415
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
|Scientific Reports|2016|263